TriCor = placebo? Not good news for Abbott - A popular triglyceride-lowering drug that has been taken by millions of Americans failed to prevent heart disease in a big federal study being presented today…more
FDA to Eli Lilly/Amylin on once-weekly Byetta: No.
OSI to Astellas: No.
FDA to Plavix (from BMS and Sanofi): black-box warning.
Negotiations Training/Presentation Training – Your sales people, account managers, leaders and executives need to grow in these skills. We’ve got the partners you need in the Impactiviti network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
JUST FOR FUN
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board